156 related articles for article (PubMed ID: 36433920)
1. New mouse models with hypomorphic SUMF1 variants mimic attenuated forms of multiple sulfatase deficiency.
Sorrentino NC; Presa M; Attanasio S; Cacace V; Sofia M; Zuberi A; Ryan J; Ray S; Petkovic I; Radhakrishnan K; Schlotawa L; Ballabio A; Lutz C; Brunetti-Pierri N
J Inherit Metab Dis; 2023 Mar; 46(2):335-347. PubMed ID: 36433920
[TBL] [Abstract][Full Text] [Related]
2. Multiple sulfatase deficiency is due to hypomorphic mutations of the SUMF1 gene.
Annunziata I; Bouchè V; Lombardi A; Settembre C; Ballabio A
Hum Mutat; 2007 Sep; 28(9):928. PubMed ID: 17657823
[TBL] [Abstract][Full Text] [Related]
3. Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.
Schlotawa L; Adang LA; Radhakrishnan K; Ahrens-Nicklas RC
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414121
[TBL] [Abstract][Full Text] [Related]
4. Late infantile form of multiple sulfatase deficiency with a novel missense variant in the SUMF1 gene: case report and review.
Sheth J; Shah S; Datar C; Bhatt K; Raval P; Nair A; Jain D; Shah J; Sheth F; Sheth H
BMC Pediatr; 2023 Mar; 23(1):133. PubMed ID: 36959582
[TBL] [Abstract][Full Text] [Related]
5. A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency.
Staretz-Chacham O; Schlotawa L; Wormser O; Golan-Tripto I; Birk OS; Ferreira CR; Dierks T; Radhakrishnan K
Mol Genet Genomic Med; 2020 Sep; 8(9):e1167. PubMed ID: 32048457
[TBL] [Abstract][Full Text] [Related]
6. Expanding the genetic cause of multiple sulfatase deficiency: A novel SUMF1 variant in a patient displaying a severe late infantile form of the disease.
Jaszczuk I; Schlotawa L; Dierks T; Ohlenbusch A; Koppenhöfer D; Babicz M; Lejman M; Radhakrishnan K; Ługowska A
Mol Genet Metab; 2017 Jul; 121(3):252-258. PubMed ID: 28566233
[TBL] [Abstract][Full Text] [Related]
7. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.
Schlotawa L; Ennemann EC; Radhakrishnan K; Schmidt B; Chakrapani A; Christen HJ; Moser H; Steinmann B; Dierks T; Gärtner J
Eur J Hum Genet; 2011 Mar; 19(3):253-61. PubMed ID: 21224894
[TBL] [Abstract][Full Text] [Related]
8. A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency.
Pham V; Sertori Finoti L; Cassidy MM; Maguire JA; Gagne AL; Waxman EA; French DL; King K; Zhou Z; Gelb MH; Wongkittichote P; Hong X; Schlotawa L; Davidson BL; Ahrens-Nicklas RC
Mol Genet Metab; 2024 Feb; 141(2):108116. PubMed ID: 38161139
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of a novel SUMF1 variation associated with a late infantile form of multiple sulfatase deficiency.
Zhang J; Ma D; Liu G; Zeng H; Wang Y; Luo C; Hu P; Xu Z
J Clin Lab Anal; 2022 Dec; 36(12):e24786. PubMed ID: 36441600
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of published cases reveals the natural disease history in multiple sulfatase deficiency.
Schlotawa L; Preiskorn J; Ahrens-Nicklas R; Schiller S; Adang LA; Gärtner J; Friede T
J Inherit Metab Dis; 2020 Nov; 43(6):1288-1297. PubMed ID: 32621519
[TBL] [Abstract][Full Text] [Related]
11. SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies.
Fraldi A; Biffi A; Lombardi A; Visigalli I; Pepe S; Settembre C; Nusco E; Auricchio A; Naldini L; Ballabio A; Cosma MP
Biochem J; 2007 Apr; 403(2):305-12. PubMed ID: 17206939
[TBL] [Abstract][Full Text] [Related]
12. Multiple sulfatase deficiency in a Turkish family resulting from a novel mutation.
Yiş U; Pepe S; Kurul SH; Ballabio A; Cosma MP; Dirik E
Brain Dev; 2008 May; 30(5):374-7. PubMed ID: 18509892
[TBL] [Abstract][Full Text] [Related]
13. Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.
Schlotawa L; Tyka K; Kettwig M; Ahrens-Nicklas RC; Baud M; Berulava T; Brunetti-Pierri N; Gagne A; Herbst ZM; Maguire JA; Monfregola J; Pena T; Radhakrishnan K; Schröder S; Waxman EA; Ballabio A; Dierks T; Fischer A; French DL; Gelb MH; Gärtner J
EMBO Mol Med; 2023 Mar; 15(3):e14837. PubMed ID: 36789546
[TBL] [Abstract][Full Text] [Related]
14. Natural history of multiple sulfatase deficiency: Retrospective phenotyping and functional variant analysis to characterize an ultra-rare disease.
Adang LA; Schlotawa L; Groeschel S; Kehrer C; Harzer K; Staretz-Chacham O; Silva TO; Schwartz IVD; Gärtner J; De Castro M; Costin C; Montgomery EF; Dierks T; Radhakrishnan K; Ahrens-Nicklas RC
J Inherit Metab Dis; 2020 Nov; 43(6):1298-1309. PubMed ID: 32749716
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency.
Cosma MP; Pepe S; Parenti G; Settembre C; Annunziata I; Wade-Martins R; Di Domenico C; Di Natale P; Mankad A; Cox B; Uziel G; Mancini GM; Zammarchi E; Donati MA; Kleijer WJ; Filocamo M; Carrozzo R; Carella M; Ballabio A
Hum Mutat; 2004 Jun; 23(6):576-81. PubMed ID: 15146462
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of SUMF1 mutations: stability and residual activity of mutant formylglycine-generating enzyme determine disease severity in multiple sulfatase deficiency.
Schlotawa L; Steinfeld R; von Figura K; Dierks T; Gärtner J
Hum Mutat; 2008 Jan; 29(1):205. PubMed ID: 18157819
[TBL] [Abstract][Full Text] [Related]
17. Biochemical signatures of disease severity in multiple sulfatase deficiency.
Adang LA; Mowafy S; Herbst ZM; Zhou Z; Schlotawa L; Radhakrishnan K; Bentley B; Pham V; Yu E; Pillai NR; Orchard PJ; De Castro M; Vanderver A; Pasquali M; Gelb MH; Ahrens-Nicklas RC
J Inherit Metab Dis; 2024 Mar; 47(2):374-386. PubMed ID: 37870986
[TBL] [Abstract][Full Text] [Related]
18. Multiple Sulfatase Deficiency: A Case Series With a Novel Mutation.
Hijazi L; Kashgari A; Alfadhel M
J Child Neurol; 2018 Nov; 33(13):820-824. PubMed ID: 30124108
[TBL] [Abstract][Full Text] [Related]
19. A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder.
Frankel LB; Di Malta C; Wen J; Eskelinen EL; Ballabio A; Lund AH
Nat Commun; 2014 Dec; 5():5840. PubMed ID: 25524633
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder.
Spampanato C; De Leonibus E; Dama P; Gargiulo A; Fraldi A; Sorrentino NC; Russo F; Nusco E; Auricchio A; Surace EM; Ballabio A
Mol Ther; 2011 May; 19(5):860-9. PubMed ID: 21326216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
